NIH Renews Sickle Cell Disease Advisory Committee Charter
Published Date: 1/23/2026
Notice
Summary
The NIH is renewing the Sickle Cell Disease Advisory Committee to keep guiding important research on sickle cell disease. This group helps decide what studies get done to better understand, treat, and prevent this condition. Their work supports ongoing efforts without any new costs or deadlines announced.
No Economic Impacts Identified for this Document
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-12244 — Center for Scientific Review; Notice of Closed Meetings
The Center for Scientific Review is holding several closed virtual meetings in July 2026 to review and decide on important research grant applications. These meetings protect private info and trade secrets while helping decide funding for health research projects. Scientists and researchers applying for grants should note these dates as they impact which projects get money.
2026-12116 — Center for Scientific Review; Notice of Closed Meetings
The Center for Scientific Review is holding several closed virtual meetings in July 2026 to review and decide on important grant applications. These meetings protect private info and trade secrets while helping fund research on mice, drug development, and primate centers. Scientists and research groups applying for grants should watch for these dates as they impact funding decisions.
2026-12106 — Submission for OMB Review; 30-Day Comment Request; NIH Extramural Harassment Web Form (Office of the Director, Office of Extramural Research)
The NIH wants to keep their Extramural Harassment Web Form active so people working with NIH grants can safely report harassment. They’re asking the public to share thoughts by July 16, 2026, but no changes or costs are involved—just a smooth continuation. This helps keep NIH’s research community respectful and safe!
2026-12070 — Government Owned Inventions Available for License: Establishment and Characterization of the A1847 Human Ovarian Carcinoma Line
The National Cancer Institute is offering a special ovarian cancer cell line called A1847 for researchers to license and use. This cell line helps scientists study how ovarian cancer grows and find better treatments, especially for tough cases linked to BRCA1 gene problems. If you’re into cancer research, this is your chance to get a powerful tool starting now, with no big costs for licensing.
2026-11892 — Proposed Collection; 60-Day Comment Request; Specimen Resource Locator (National Cancer Institute)
The National Cancer Institute wants your thoughts on a new way to track and locate cancer research samples through their Specimen Resource Locator. This affects researchers and labs who use these samples, aiming to make finding and sharing easier without adding extra costs or delays. You’ve got 60 days to share your feedback and help shape this helpful tool!
2026-11390 — Center for Scientific Review; Notice of Closed Meetings
The Center for Scientific Review is holding several closed virtual meetings in July 2026 to review and decide on important research grant applications. These meetings protect private info and trade secrets while helping decide who gets funding to advance science. Researchers applying for grants should note these dates as they impact funding decisions but don’t involve public attendance or extra costs.
Previous / Next Documents
Previous: 2026-01312 — Information Collection Being Reviewed by the Federal Communications Commission Under Delegated Authority
The FCC is checking in on a paperwork form called the ARMIS Annual Summary Report, which businesses must fill out every year. They want your thoughts on how to make this process easier and less time-consuming, especially for small businesses. If you have ideas, send them in by March 24, 2026—this helps keep things smooth and saves everyone time and money!
Next: 2026-01315 — Underground Injection Control Program; Hazardous Waste Injection Restrictions; Petition for Exemption Reissuance-Class I Hazardous Waste Injection; Sasol Chemicals (USA), LLC, Greens Bayou Plant, Texas
Sasol Chemicals in Houston got the green light to keep safely injecting certain hazardous wastes underground until 2050. This means they can continue their work without moving dangerous stuff around, keeping the environment safe. The decision took effect in December 2025 and followed a public comment period with two responses.